ISENTRESS

CHEBI:CHEBI_755895

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
744842
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
route
ORAL
listing_expiration_date
20241231
dosage_form
TABLET, FILM COATED
active_ingredient_strength
400 mg/1
labeler_name
Direct_Rx
manufacturer_name
Direct_Rx
active_ingredient_name
RALTEGRAVIR POTASSIUM
marketing_start_date
20161221
package_marketing_start_date
20161221
generic_name
ISENTRESS
brand_name
ISENTRESS
brand_name_base
ISENTRESS
application_number
NDA022145
unii
43Y000U234
pharm_class
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
product_ndc
61919-706
spl_id
d5e239df-4a66-354f-e053-2995a90a1a57
package_ndc
61919-706-06
package_description
6 TABLET, FILM COATED in 1 BOTTLE (61919-706-06)
spl_set_id
442d9e67-1c2c-73f8-e054-00144ff8d46c
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class